Emerging Trends Influencing The Growth Of The Liver Cirrhosis Market: Introduction Of Innovative Implantable Device Approved For Advanced Treatment

The Liver Cirrhosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Liver Cirrhosis Market Size Expected to Be by 2034?
Recent years have witnessed a swift expansion in the market size for liver cirrhosis. Projected to escalate from $1.86 billion in 2024 to a sizeable $2.01 billion in 2025, the market is set to exhibit a compound annual growth rate (CAGR) of 8.3%. This notable growth during the historic period can be credited to factors such as the rising occurrence of liver-related ailments, augmented alcohol intake, a growing aging population, escalated spending on healthcare, and increased initiatives from the government.

The market size of liver cirrhosis is anticipated to experience swift expansion in the upcoming years, projecting a worth of $2.74 billion by 2029, due to a compound annual growth rate (CAGR) of 8.0%. The anticipated growth during this period can be assigned to the increase in hepatitis infections, economic augmentation, escalating urbanization and lifestyle alterations, along with the rise of medical tourism. The period also predicts significant trends like progress in diagnostic instruments, technological advancements, cooperation and collaboration, the incorporation of artificial intelligence, and the adoption of comprehensive therapies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

What Are the Emerging Segments Within the Liver Cirrhosis Market?
The liver cirrhosis market covered in this report is segmented -

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis
2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments
3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis
2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis
3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis
4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis
5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Long-Term Drivers Are Shaping Liver Cirrhosis Market Trends?
The surge in the intake of alcoholic drinks is predicted to spur the growth of the liver cirrhosis market in the future. The consumption of alcohol covers the ingestion of alcohol-based beverages, usually quantified in terms of volume and frequency. More and more individuals are turning to alcohol to relieve daily stress, strengthen social bonds during events, and elevate relaxation periods. Also, it's increasingly being spotlighted in the media and is more readily available in multiple environments. Treatment of liver cirrhosis for patients who overconsume alcohol centers on halting liver damage with abstention, medication, and supportive care, while simultaneously addressing alcohol addiction with therapy and rehabilitation. For instance, the National Drugs Library, an organization based in Ireland that collects data, reported in March 2023 that in 2022, the standard alcohol intake for individuals over 15 years increased to 10.2 liters of pure alcohol per capita. This indicates a 7.6% growth from 2021. Therefore, the rise in alcohol consumption is propelling the liver cirrhosis market.

Who Are the Top Competitors in Key Liver Cirrhosis Market Segments?
Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

What Liver Cirrhosis Market Trends Are Gaining Traction Across Different Segments?
Leading businesses in the liver cirrhosis marketplace are placing significant emphasis on enhancing treatment methods, such as the creation of active implantable medical devices, in order to improve patient prognosis and broaden the potential therapies. These active implantable medical devices are electronic implants engineered to track, assist, or enhance organ function internally. As an example, Sequana Medical NV, a medical device firm based in Belgium, in December 2024, obtained approval from the U.S. FDA for its alfapump system, which is the first active implantable medical gadget in the U.S. used for monitoring recurrent or refractory ascites resulting from liver cirrhosis. This pioneering technology provides a constant, automated fluid managing system by moving excessive abdominal fluid to the bladder thereby significantly reducing the reliance on therapeutic paracentesis, an invasive procedure. Alfapump is a significant step forward in enhancing patient prognosis and improving the quality of life and is relevant to a market of roughly 70,000 patients in the U.S.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Regions Are Becoming Hubs for Liver Cirrhosis Market Innovation?
North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Cirrhosis Market?
2. What is the CAGR expected in the Liver Cirrhosis Market?
3. What Are the Key Innovations Transforming the Liver Cirrhosis Industry?
4. Which Region Is Leading the Liver Cirrhosis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.